Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperparathyroid bone disease in chronic renal failure.

T Cundy, N Hamdy, R Gray

    The Ulster Medical Journal
    |August 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Measurement of the centrality dependence of the charged-particle pseudorapidity distribution in proton-lead collisions at [Formula: see text] TeV with the ATLAS detector.

    The European physical journal. C, Particles and fields·2017
    Same author

    Measurement of the Inelastic Proton-Proton Cross Section at sqrt[s]=13  TeV with the ATLAS Detector at the LHC.

    Physical review letters·2016
    Same author

    Search for Higgs and Z Boson Decays to ϕγ with the ATLAS Detector.

    Physical review letters·2016
    Same author

    Acute photosensitisation and mortality in a herd of dairy cattle in Tasmania.

    New Zealand veterinary journal·2016
    Same author

    Identification of boosted, hadronically decaying <i>W</i> bosons and comparisons with ATLAS data taken at [Formula: see text] TeV.

    The European physical journal. C, Particles and fields·2016
    Same author

    Observation of Long-Range Elliptic Azimuthal Anisotropies in sqrt[s]=13 and 2.76 TeV pp Collisions with the ATLAS Detector.

    Physical review letters·2016
    Same journal

    Curiositas - Medicine in the Kitchen.

    The Ulster medical journal·2026
    Same journal

    Royal Victoria Hospital Annual Oration, 3rd October 2025.

    The Ulster medical journal·2026
    Same journal

    Thrombosis and Survival after Prothrombin Complex Concentrate Use to treat Oral Anticoagulant Associated Haemorrhage.

    The Ulster medical journal·2026
    Same journal

    Investigating Iron Deficiency Anaemia in the Elderly.

    The Ulster medical journal·2026
    Same journal

    Avoiding Prescribing Pitfalls to Tackle Problematic Polypharmacy and Adverse Drug Reactions in Northern Ireland.

    The Ulster medical journal·2026
    Same journal

    Sir Benjamin William Rycroft: Reflections on Character and Career.

    The Ulster medical journal·2026
    See all related articles

    Over 80 years, hyperparathyroid bone disease in kidney failure has shifted from a rare childhood issue to a common dialysis complication. While treatments exist, they are not curative, necessitating further research for better understanding and prevention.

    Area of Science:

    • Nephrology
    • Endocrinology
    • Bone Metabolism

    Background:

    • Hyperparathyroid bone disease in renal failure has been studied for 80 years.
    • It has evolved from a rare childhood disorder to a prevalent complication in dialysis patients.
    • This condition presents significant clinical challenges in chronic kidney disease management.

    Purpose of the Study:

    • To review the pathogenesis and management of hyperparathyroid bone disease in uraemia.
    • To highlight the clinical evolution of this disorder over eight decades.
    • To identify the need for further research in treatment and prevention.

    Main Methods:

    • Literature review spanning 80 years of research.
    • Analysis of clinical presentation and management strategies.

    Related Experiment Videos

  • Evaluation of current treatment efficacy and limitations.

    • Main Results:

    • Significant advancements in understanding pathogenesis and management.
    • Shift in clinical prevalence from rare childhood cases to common dialysis-related problems.
    • Availability of effective, yet non-curative, treatments.

    Conclusions:

    • Hyperparathyroid bone disease in uraemia remains a complex and challenging condition.
    • Current treatments offer management but not a cure.
    • Further research is essential for a comprehensive understanding and improved therapeutic strategies.